GMP-certified pharma manufacturer with R&D, distribution, and regulated market exports
Dexa Group operates a vertically integrated pharmaceutical platform across research, manufacturing, distribution, and regulatory compliance, with EU-GMP certification and export capability in regulated markets. Recent hiring is sales-heavy (13 of 18 active roles), suggesting aggressive market expansion or partnership pipeline pressure; the lean engineering footprint (2 roles) indicates a mature, stable platform rather than active product rebuilds.
Dexa Group is a 5,000–10,000-person pharmaceutical manufacturer headquartered in Tangerang Selatan, Indonesia, with public company status since 1969. The business spans R&D, advanced pharmaceutical manufacturing under EU-GMP standards, national distribution, and international regulatory navigation. The company pursues direct partnerships with global pharmaceutical entities and consumer health brands. Tech infrastructure leans on a modern web/data stack (React, Node.js/NestJS, MySQL/PostgreSQL, GCP, Oracle, Power BI) supporting both internal operations and partner-facing systems.
Dexa holds EU-GMP (Good Manufacturing Practice) certification, enabling export into regulated pharmaceutical markets globally.
Frontend: React, Tailwind CSS, TypeScript. Backend: Node.js, NestJS, Express.js, PHP, Java. Data: MySQL, PostgreSQL, MongoDB, Redis, Oracle, Hadoop, Apache Spark. BI: Power BI, Tableau. Cloud: GCP.
Dexa Group's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.